Saturday - April 19, 2025

Dimeric Immuno-Modulatory Compounds Against Cereblon-Based Mechanisms

2025-02-25

ALEXANDRIA, Virginia, Feb. 25 -- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., Tampa, Florida has been assigned a patent (No. US 12233054 B2, initially filed Aug. 21, 2023) developed by three inventors Pearlie Burnette, Tampa, Florida; Nicholas J. Lawrence, Tampa, Florida; and Harshani Lawrence, Tampa, Florida, for "Dimeric immuno-modulatory compounds against cereblon-based mechanisms." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Dimeric Immuno-Modulatory Compounds Against Cereblon-Based Mechanisms

Information Request Form

Copyright Targeted News Service 2025